Combined Therapies for PTSD
Trial Summary
What is the purpose of this trial?
This trial tests a combined therapy for Veterans with PTSD at high risk for suicide. The treatment helps manage emotions and process trauma, aiming to reduce both PTSD symptoms and suicidal behaviors. This therapy has been shown to reduce suicidal thoughts and emotional instability among Veterans.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What data supports the effectiveness of this treatment for PTSD?
Research shows that combining Dialectical Behavior Therapy (DBT) with the Prolonged Exposure (PE) protocol can significantly reduce PTSD symptoms, especially when compared to DBT alone. Additionally, PE therapy has been effective in reducing PTSD symptoms in veterans and emergency service personnel, indicating its broader applicability.12345
Is the combined therapy for PTSD safe for humans?
How is the Combined Therapies for PTSD treatment different from other treatments for PTSD?
The Combined Therapies for PTSD treatment is unique because it integrates Dialectical Behavior Therapy (DBT) with the Prolonged Exposure (PE) protocol, specifically targeting both behavioral issues and PTSD symptoms in a structured, stage-based approach. This combination aims to enhance the effectiveness of DBT by incorporating PE, which is a well-established method for reducing PTSD symptoms, offering a comprehensive treatment for individuals with complex conditions like borderline personality disorder and PTSD.128910
Research Team
Melanie S Harned, PhD
Principal Investigator
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Eligibility Criteria
This trial is for Veterans with PTSD who are at risk of suicide. They must be eligible for VHA mental health care, have emotion dysregulation and recent self-harm, be over 18, willing to participate in all study activities, and currently have suicidal thoughts. Those already treated with DBT or PE recently, unable to stay safe on their own, planning to move away soon or unable to understand the study due to language or cognitive issues can't join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either DBT + DBT PE or PE + SRM for PTSD and suicide risk management
Follow-up
Participants are monitored for safety and effectiveness after treatment
Implementation Evaluation
Evaluation of barriers and facilitators to implementation of treatments
Treatment Details
Interventions
- Dialectical Behavior Therapy (Behavioral Intervention)
- Dialectical Behavior Therapy Prolonged Exposure protocol (Behavioral Intervention)
- Prolonged Exposure therapy (Behavioral Intervention)
- Suicide risk management (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor
Dr. Grant Huang
VA Office of Research and Development
Acting Chief Research and Development Officer
PhD in Medical Psychology and Master of Public Health from the Uniformed Services University of Health Sciences
Dr. Erica M. Scavella
VA Office of Research and Development
Chief Medical Officer since 2022
MD from University of Massachusetts School of Medicine